Nautilus Biotechnology, Inc.
NAUT
$0.723
$0.0233.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.61M | -17.59M | -16.45M | -18.01M | -18.73M |
| Total Depreciation and Amortization | 1.63M | 1.55M | 1.61M | 1.60M | 1.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.63M | 3.34M | 2.46M | 2.58M | 2.36M |
| Change in Net Operating Assets | -576.00K | -1.61M | -740.00K | -1.62M | -1.49M |
| Cash from Operations | -13.94M | -14.31M | -13.11M | -15.46M | -16.27M |
| Capital Expenditure | -219.00K | -1.01M | -709.00K | -512.00K | -647.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 19.73M | 38.12M | -6.79M | 14.81M | 23.00M |
| Cash from Investing | 19.51M | 37.11M | -7.50M | 14.29M | 22.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.00K | 440.00K | 140.00K | 319.00K | 245.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18.00K | 440.00K | 140.00K | 319.00K | 245.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.59M | 23.24M | -20.48M | -844.00K | 6.33M |